Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amdocs (DOX) EBT (2016 - 2025)

Historic EBT for Amdocs (DOX) over the last 17 years, with Q4 2025 value amounting to $195.4 million.

  • Amdocs' EBT rose 155.49% to $195.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $696.2 million, marking a year-over-year increase of 1433.54%. This contributed to the annual value of $693.2 million for FY2025, which is 1728.57% up from last year.
  • Per Amdocs' latest filing, its EBT stood at $195.4 million for Q4 2025, which was up 155.49% from $120.8 million recorded in Q3 2025.
  • In the past 5 years, Amdocs' EBT registered a high of $195.4 million during Q4 2025, and its lowest value of $103.4 million during Q3 2024.
  • In the last 5 years, Amdocs' EBT had a median value of $162.9 million in 2022 and averaged $160.9 million.
  • As far as peak fluctuations go, Amdocs' EBT crashed by 5346.44% in 2021, and later skyrocketed by 3136.27% in 2025.
  • Quarter analysis of 5 years shows Amdocs' EBT stood at $167.6 million in 2021, then fell by 13.41% to $145.1 million in 2022, then grew by 20.29% to $174.6 million in 2023, then rose by 10.24% to $192.4 million in 2024, then increased by 1.55% to $195.4 million in 2025.
  • Its last three reported values are $195.4 million in Q4 2025, $120.8 million for Q3 2025, and $190.8 million during Q2 2025.